Business Operations Team
Ken Accardi, MBA, Boston, MA
Ken was the CIO for the $3B Service Division of GE Medical Systems. Since leaving GE, Ken was Vice President of Business Solutions for the software Company ViryaNet, Inc. and Vice President of Global Processes and Quality for Tele Atlas (recently sold to Tom Tom). Ken works with MedNest on assignments related to the convergence of Information Technology with Medical Devices and Drugs
Tracy Accardi, MS, Boston, MA
Tracy offers +20 years of experience in Product Development in Medical Device, with past R&D leadership roles for GE Healthcare, Philips (Diagnostic Imaging), Johnson and Johnson (Device) and most recently Covidien. Tracy is an active Member of the Massachusetts Medical Device industry ecosystem.
Denise Carpenter, Princeton, NJ
As a former Manager of Regulatory Affairs at J&J Cardiovascular and successful consultant for 10 years in regulatory affaires specialized in Medical Devices and Combinatoin products, Denise brings more that 22 years of operational Regulatory and Quality Compliance experience.
Susan Paquette, MS, MBA, Minneapolis, MN
Susan has over 25 years of experience in leadership positions at 3M related to the identification and championing of significant new growth platforms. Susan most recently worked in 3M Health Care as Director of Commercialization. In this role she worked with the Skin and Wound Care, Infection Prevention, Dental, Drug Delivery, Patient Assessment and Orthodontic business units of 3M. Susan has experience in business development, laboratory management, market development, product development and manufacturing support.
Mathieu Petitjean, Ph.D., Princeton, NJ
Former Chief Marketing Officer at General Electric and Leader of P&L Operations at GE Healthcare. Held several business, product and technology leadership roles with GE Clinical Services and GE Medical systems in 6 different European, American and Latin-American markets. He started his career in Europe and Japan with several high technology start-up companies.
| Medical and Industry Advisory Team
Dennis Donohue, MD:
Former World Wide VP Clinical Research, J&J Cordis, Ethicon
22 years of global experience in Clinical research and regulatory Affairs (Phase I to IV) in Devices and Diagnostics, with a specific focus on Combination Products, across many Therapeutic Areas.
Joe Camaratta, MBA
Senior VP Global Sales and Marketing at Power Medical Interventions, a provider of innovative, computed-assisted surgical instruments. former VP of SIEMENS Healthcare Global Solutions, providing performance improvement services to hospitals and integrated delivery network care providers. He also led Corporate Marketing for Siemens Healthcare, and was VP/P&L Manager of the U.S MRI Imaging Business. He had several roles in product Development and Research and Development in the MRI and Medical Imaging fields.
Eliot Heller, MD
CMIO of Bronx-Lebanon Hospital Center with responsibility of managing and implementing all aspects of hospital information system. Previously Chief of Cardiology and Director of Nuclear Cardiology. With over 15 years of experience within clinical and academic medicine. Experience includes clinical cardiology, information system design & implementation, project management, programming, cardiac imaging, practice management, physician training, clinical and basic research.
Dominick Ethgen, MD
Executive Director at Medimune
20 years of Clinical research experience including pre-clinical into First Time in Human and Proof of Concept and Designing and executing large phase II/III program mainly in Rheumatology, Musculoskeletal Diseases, Osteoarthritis, Metabolic Diseases and Endocrinology, Internal Medicine
Steve Owens, MS
Innovation Sourcing Leader at Forest Lab, and Former CIO of CRO and Imaging Core Lab Radpharm, Steve is a practical leader with vast experience in Clinical Research methodologies including large programs, budget and quality management experience. Prior to his role at RadPharm, Steve was the Head of Siemen’s Center for Imaging and Innovation in Princeton.
Michele Mercuri, MD, PhD
VP Clinical Development in Cardiology at Daiichi Sankyo. Former VP of Global Methodology and Innovation in Pharma development at Novartis.
20 years of experience across the continuum of clinical drug development and in particular the use of medical technologies and Translational Medicine to enhance clinical research in metabolic disease, atherosclerosis, neurosciences.
Richard H. Wildnauer, Ph.D, MBA
Richard was formerly president and CEO of NeoStrata Company and president of Baker Cummins/Dermablend, two dermatological/skincare companies. Prior to these roles, Richard held both R&D and Business/Market Development executive positions at three J&J Operating Companies and in J&J Corporate as Corporate Vice President for Skin Care Technology and Chairman of the Skin Care Council of Research.
|
